KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Capital Employed: 2018-2024

Historic Return on Capital Employed for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to 0.51%.

  • Aquestive Therapeutics' Return on Capital Employed fell 33.00% to 0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54%, marking a year-over-year decrease of 33.00%. This contributed to the annual value of 0.51% for FY2024, which is 12.00% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Return on Capital Employed of 0.51% as of FY2024, which was down 31.01% from 0.39% recorded in FY2023.
  • Aquestive Therapeutics' Return on Capital Employed's 5-year high stood at 0.39% during FY2023, with a 5-year trough of 2.10% in FY2022.
  • In the last 3 years, Aquestive Therapeutics' Return on Capital Employed had a median value of 0.51% in 2024 and averaged 1.00%.
  • Per our database at Business Quant, Aquestive Therapeutics' Return on Capital Employed crashed by 125bps in 2022 and then surged by 172bps in 2023.
  • MRY analysis of 5 years shows Aquestive Therapeutics' Return on Capital Employed stood at 0.87% in 2020, then rose by 1bps to 0.86% in 2021, then crashed by 145bps to 2.10% in 2022, then skyrocketed by 82bps to 0.39% in 2023, then plummeted by 31bps to 0.51% in 2024.
  • Its last three reported values are 0.51% in FY2024, 0.39% for FY2023, and 2.10% during FY2022.